Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Zumedha Equity Research Zumedha Equity Research

Research · Analysis · Insights

Zumedha Equity Research Zumedha Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds Reviews
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Calculators
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds Reviews
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Calculators
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Zumedha Equity Research Zumedha Equity Research

Research · Analysis · Insights

Zumedha Equity Research Zumedha Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds Reviews
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Calculators
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds Reviews
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Calculators
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Home/Banking & Finance/Pine Labs DCF Valuation and Stock price Analysis Aug 2026
Banking & Finance

Pine Labs DCF Valuation and Stock price Analysis Aug 2026

August 5, 2026 8 Min Read
Zumedha Equity ResearchResearch . Analysis . Insights
Hold / Accumulate on Dips
₹139
as on 03 Aug 2026

Pine Labs Ltd

India’s largest independent merchant commerce platform — digital payments, issuing and fintech infrastructure across 8 countries, now navigating its first year as a public, profit-turning company.
NSEPINELABS
BSE544606
ISININE15B701018
Face Value₹1.00
52W High/Low₹284 / ₹135
Mkt Cap~₹15,950 Cr
Shares O/S~114.7 Cr
Avg Volume~1.5–2 Cr/day
IndexNifty 500, Smallcap 100
Major HoldersPeak XV, Temasek, PayPal
P/E (TTM)
~123x
P/B
2.7x
Revenue FY26
₹2,711 Cr
PAT FY26
₹113 Cr
01 / 13

Business Overview

Incorporated in 1998 and headquartered in Gurugram/Noida, Pine Labs began as a point-of-sale (POS) technology provider and has evolved into a full-stack “Commerce OS” spanning three broad lines: (a) digital payments — in-store POS and online payment gateway solutions; (b) issuing — prepaid instruments, gift cards, and card-issuance infrastructure for brands, retailers and travel/hospitality clients; and (c) fintech infrastructure — white-labelled technology for roughly 200 banks and financial institutions, including credit-processing and merchant-financing rails.

The company serves over a million merchants and operates across India, Malaysia, UAE, Singapore, Australia, the US and parts of Africa, giving it a rare cross-border footprint among Indian payments players. Pine Labs is backed by marquee investors including Peak XV Partners (formerly Sequoia India), Temasek, PayPal, Actis and Altimeter, and is led by Executive Chairman & MD Amrish Rau.

Pine Labs listed on the NSE/BSE in November 2025 at an issue price of ₹221 (price band ₹210–221), debuting at a ~9.5% premium. The listing followed a long and turbulent pre-IPO journey — the company had originally targeted a much larger valuation in 2021–22 before recalibrating expectations amid the global fintech de-rating. Since listing, the stock has fallen sharply from its post-listing high, reflecting the market’s re-pricing of a business that only turned consolidated-profitable in FY26. The company has also been leaning into AI, integrating OpenAI-linked tooling into its merchant workflows, and recently acquired checkout-conversion startup Shopflo for ~₹88 crore.

Merchants Served
1 Mn+
Financial Institution Clients
~200
Geographies
7–8 Countries
IPO Listing (Nov 2025)
₹221 → ₹242
02 / 13

Historical Financials

Pine Labs’ revenue has compounded at roughly 32% CAGR over five years, but profitability has been the real story of the last twelve months. After six consecutive years of net losses (FY20–FY25), the company delivered its first full-year consolidated net profit in FY26 — ₹113 crore on revenue of ₹2,711 crore — aided by operating leverage as the operating margin expanded from -1% (FY24) to 13% (FY26). Free cash flow also turned positive (₹161 crore) in FY26 for the first time in the disclosed history, a meaningfully more important inflection than the headline PAT number.

₹ CrFY22FY23FY24FY25FY26
Sales9321,5981,7702,2742,711
Operating Profit1125-25218358
OPM %12%0%-1%10%13%
Other Income25565516133
Depreciation189315363292270
PBT-75-289-398-136137
Net Profit-23-265-342-145113
EPS (₹)-1.67-18.99-4.07-1.730.98
Free Cash Flow-407-517-486-99161
5-Yr Sales CAGR
32%
5-Yr Profit CAGR
32%
3-Yr ROE (avg)
-3%
FY26 ROE / ROCE
2.5% / 4.2%
03 / 13

DCF Valuation

A 10-year FCFF DCF is inherently fragile here: Pine Labs generated positive free cash flow for the first time only in FY26, so the model rests almost entirely on assumed forward improvement rather than an established track record. We model revenue growth tapering from 20% to 10% over ten years (broadly in line with management’s ~20% near-term guidance) alongside FCF margin expanding from ~6% to ~17% as scale and operating leverage take hold — a trajectory consistent with mature global payments platforms, but by no means guaranteed for Pine Labs specifically.

Discounted Cash Flow — Base Case

WACC
12.0%
Terminal Growth
5.0%
PV of 10-Yr FCF
₹4,396 Cr
PV of Terminal Value
₹8,887 Cr
Enterprise Value
₹13,283 Cr
Implied Value / Share
~₹116

At a base-case DCF value of ~₹116/share against a CMP of ₹139, the model implies the stock is trading at a premium to a conservatively-modelled intrinsic value — unsurprising for a business the market is pricing predominantly on growth optionality rather than discounted cash flows. Small changes in the assumed FCF-margin trajectory move this output by ±25–30%, so this figure should be treated as one directional input, not a precise target.

04 / 13

Relative Valuation & Peer Multiples

Pine Labs has no exact listed peer in India — it straddles payment gateways, POS hardware/software, issuing and BaaS infrastructure. The closest reference points are other listed new-age fintech/platform businesses (PB Fintech, One97 Communications/Paytm) and, for sanity-checking, EV/Sales multiples used globally for payments infrastructure companies.

MetricPine LabsSector Range (approx.)
P/E (TTM)~123xLoss-making to 60–100x for growth fintech
P/B2.7x2–6x for asset-light platforms
EV/Sales~5.4x3–8x for scaled payments platforms
OPM13%10–30% (wide range by mix)

On EV/Sales, Pine Labs does not look egregiously expensive for a company compounding revenue at ~19–20% with margins now inflecting positively. The P/E multiple is elevated in absolute terms, but that is largely an artefact of FY26 being the first meaningfully profitable year — as the earnings base normalises over FY27–FY29, the multiple should compress mechanically if growth and margin guidance are met.

05 / 13

Asset-Based / NAV

Pine Labs is a technology and services business with a light physical-asset base; book value is dominated by reserves built from IPO proceeds and accumulated capital rather than hard assets. Book value stands at ₹51.3/share, against which the stock trades at 2.7x — a premium justified only by expected future earnings power, not by liquidation or replacement value of underlying assets. An asset/NAV lens is therefore of limited use as a valuation anchor for this business and is included here mainly as a floor-value reference.

Book Value / Share
₹51.3
P/B (CMP)
2.71x
Total Reserves
₹5,781 Cr
Borrowings
₹441 Cr
06 / 13

Earnings Power Value (EPV)

EPV strips out growth assumptions entirely and asks: what is the business worth if current, normalized earnings simply persist forever? Using FY26 operating profit of ₹358 crore less depreciation of ₹270 crore gives an EBIT of ~₹88 crore; tax-effected, this is a NOPAT of roughly ₹66 crore. Capitalised at a 12% WACC with no growth, EPV works out to approximately ₹550 crore, or under ₹5 per share.

The enormous gap between this ₹5 EPV and the ₹139 CMP is the clearest illustration that Pine Labs is priced almost entirely on the market’s belief in a multi-year margin-expansion and growth story, not on what the company earns today. This is not unusual for a business one year removed from its first profitable year, but it does mean the stock has very little cushion if growth or margin delivery disappoints.

07 / 13

Sum-of-the-Parts (SOTP)

Pine Labs does not disclose granular segment-level P&L (revenue, EBITDA by digital payments / issuing / fintech infrastructure) in public filings, which limits the precision of a formal SOTP. Directionally: the digital payments and fintech-infrastructure businesses are the higher-growth, higher-multiple segments (comparable to payment gateway/BaaS peers commanding 5–10x EV/Sales), while the issuing/prepaid-instruments business is a more mature, lower-growth, lower-multiple segment (2–4x EV/Sales) given its more commoditised, card-and-voucher-led economics. A blended EV/Sales in the 5–6x range — roughly where the stock trades today — appears consistent with this mix, without materially disconfirming or validating the current price.

08 / 13

Buy Range

Strong Buy
Below ₹100
Accumulate
₹100 – ₹125
Fair Value
₹125 – ₹150

At the current ₹139, the stock sits inside the Fair Value band, closer to its upper edge — not a compelling entry for fresh, large allocations, but not stretched either. A pullback toward ₹100–125 (still well above the post-listing 52-week low of ₹135, note this band assumes further de-rating is possible) would offer a materially better risk-reward for long-term accumulation.

09 / 13

Buy Scenario

Bear
₹70–90
Growth slows below 12%, margin gains stall, PE-investor overhang triggers a supply-driven de-rating.
Base
₹150–180
Revenue compounds ~18–20%, OPM expands toward high-teens over FY27–FY29, multiple re-rates modestly as earnings base grows.
Bull
₹230–260
International/AI-led growth surprises, margins scale faster than guided, sustained institutional buying absorbs pre-IPO investor selling.
10 / 13

Sell Range

Reduce
₹180 – ₹220
Exit
₹220 – ₹260
Avoid Fresh Buying
Above ₹260

Levels above ₹220–260 would put the stock back near its post-listing highs, at which point the P/E would likely be back in the 180–220x range on trailing earnings — a valuation that would need very high confidence in multi-year margin expansion to justify holding through.

11 / 13

Sell Scenario

Structural Break Triggers

  • A reversal back into operating losses, or margin compression instead of expansion, for two-plus consecutive quarters
  • Large-scale, coordinated selling by pre-IPO PE/VC investors (Peak XV, Temasek, PayPal, Actis, Altimeter) once lock-ins expire
  • Adverse RBI/regulatory action on payment aggregators or prepaid instruments materially impacting the issuing business
  • Loss of major bank or enterprise client relationships to competitors (Razorpay, Juspay, PayU, Paytm)
12 / 13

Future Growth

Management has guided to ~20% revenue growth with continued EBITDA margin expansion into FY27, driven by AI-led automation of merchant workflows, deeper monetisation of the issuing and fintech-infrastructure businesses, and international expansion in Southeast Asia, the Middle East and Africa. The recent Shopflo acquisition adds checkout-conversion technology that should help cross-sell into the existing merchant base. Structurally, continued formalisation of Indian commerce, growth in digital/UPI transaction volumes, and rising demand from banks for white-labelled fintech infrastructure all provide multi-year tailwinds, though these are shared with several well-funded competitors.

13 / 13

Risks & Catalysts

Bull Case / Catalysts

  • Sustained margin expansion validating the operating-leverage thesis over FY27–FY28
  • Successful international and AI-product monetisation lifting growth above guided 20%
  • Index inclusion and rising institutional (DII/FII) ownership as float stabilises post-IPO
  • Further bolt-on M&A (like Shopflo) expanding the product stack and merchant stickiness

Bear Case / Risks

  • Six-year history of losses and negative FCF prior to FY26 — the profitable track record is one year old
  • Intense, well-capitalised competition compressing take-rates in payments and issuing
  • High trailing P/E leaves little room for execution missteps
  • Pre-IPO investor overhang as lock-in periods lapse through 2026–2027
  • Regulatory risk inherent to payment aggregators and prepaid-instrument issuers in India
Verdict

Weighing all methods together — a DCF anchored near ₹116, an EPV of under ₹5 reflecting today’s earnings alone, book value of ₹51, and a relative-valuation picture that looks reasonable on EV/Sales but stretched on trailing P/E — this analysis suggests Pine Labs is a business whose fundamentals genuinely improved in FY26, but whose stock price at ₹139 already embeds a fair amount of that improvement continuing for several more years. For a long-term investor comfortable with execution and overhang risk, staggered accumulation on weakness toward the ₹100–125 zone looks more attractive than buying at current levels; this analysis suggests a Hold on existing positions and patience over aggressive fresh buying at ₹139, with a 3–5 year horizon needed for the growth thesis to play out.

Disclaimer: This report is prepared by Zumedha Equity Research (zumedha.com) for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer/solicitation to buy or sell any security. Figures are sourced from company filings, exchange disclosures and third-party financial data platforms as of early August 2026 and may contain errors or become outdated; readers should independently verify all data before making investment decisions. Pine Labs listed on the NSE/BSE only in November 2025 — its public financial and price history is short, and historical patterns may not be indicative of future performance. Equity investments are subject to market risk, and past performance is not indicative of future results. The author(s) may or may not hold a position in the security discussed. Please consult a SEBI-registered investment advisor before making investment decisions.

Tags:

Commerce PlatformsFintechPine Labs
Author

Zumedha Research Team

Follow Me
Other Articles
Previous

Data Patterns (India) Ltd DCF Valuation and Stock Analysis July 2026

Next

Niva Bupa Health Insurance Valuation and Stock Price Analysis Aug 2026

  • Niva Bupa Health Insurance Valuation and Stock Price Analysis Aug 2026
  • Pine Labs DCF Valuation and Stock price Analysis Aug 2026
  • Data Patterns (India) Ltd DCF Valuation and Stock Analysis July 2026
  • Adani Green Energy Ltd DCF Valuation and Stock Analysis July 2026
  • Sona BLW Precision Forgings DCF Valuation and Stock Price Analisys June 2026

Financial Tools & Calculators

  • Mutual Fund SIP Calculator
  • Tax Calculator
  • EMI Calculator
  • Inflation Calculator
  • Loan Calculator
© 2026 · All Rights Reserved. RESEARCH · ANALYSIS · INSIGHTS # About Us | Terms of Use | Privacy Policy | Disclaimer | Contact Us